SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 325 filers reported holding SEATTLE GENETICS INC in Q2 2019. The put-call ratio across all filers is 0.72 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $769,000 | -23.6% | 3,929 | -33.7% | 0.07% | -28.9% |
| Q2 2020 | $1,007,000 | +123.8% | 5,929 | +52.0% | 0.10% | +90.2% |
| Q1 2020 | $450,000 | +0.9% | 3,900 | 0.0% | 0.05% | +27.5% |
| Q4 2019 | $446,000 | +33.9% | 3,900 | 0.0% | 0.04% | +17.6% |
| Q3 2019 | $333,000 | +23.3% | 3,900 | 0.0% | 0.03% | +21.4% |
| Q2 2019 | $270,000 | -31.8% | 3,900 | -27.9% | 0.03% | -36.4% |
| Q1 2019 | $396,000 | – | 5,410 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 50,060,240 | $5,775,950,000 | 35.57% |
| Lagoda Investment Management, L.P. | 72,969 | $8,419,000 | 9.97% |
| Avidity Partners Management LP | 580,000 | $66,920,000 | 9.25% |
| Arabesque Asset Management Ltd | 14,807 | $1,708,000 | 3.53% |
| Boxer Capital, LLC | 400,000 | $46,152,000 | 3.15% |
| Woodline Partners LP | 364,333 | $42,037,000 | 3.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 56,900 | $6,557,000 | 2.99% |
| SECTORAL ASSET MANAGEMENT INC | 107,000 | $12,346,000 | 2.37% |
| Capital International, Inc./CA/ | 1,197,659 | $138,186,000 | 2.33% |
| Bain Capital Public Equity Management II, LLC | 169,641 | $19,573,000 | 2.29% |